Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats

Antibody-mediated rejection (AMR) remains a refractory rejection after donor-specific antibody (DSA)-positive or blood-type incompatible liver transplantation (LT), even in the era of pre-transplant rituximab desensitization. This is due to the lack of not only effective post-transplant treatments b...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajima, Tetsuya, Hata, Koichiro, Kusakabe, Jiro, Miyauchi, Hidetaka, Badshah, Joshua Sam, Kageyama, Shoichi, Zhao, Xiangdong, Kim, Sung-Kwon, Tsuruyama, Tatsuaki, Kirchner, Varvara A., Watanabe, Takeshi, Uemoto, Shinji, Hatano, Etsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313232/
https://www.ncbi.nlm.nih.gov/pubmed/37398677
http://dx.doi.org/10.3389/fimmu.2023.1186653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313232/
https://www.ncbi.nlm.nih.gov/pubmed/37398677
http://dx.doi.org/10.3389/fimmu.2023.1186653

Ejemplares similares